Toledano Miranda Jayne 4

What Happened

• Miranda Jayne Toledano, a director of Journey Medical Corp (DERM), was granted 10,000 restricted stock units (RSUs) on June 25, 2026. The Form 4 reports an acquisition (code A) of 10,000 shares at $0.00 (an awarded grant, not a market purchase or sale).
• The grant will vest in full for 10,000 shares on June 25, 2027 per the filing. Because this is a compensation award, there was no cash outlay by the insider and no immediate sale.

Key Details

• Transaction date: 2026-06-25 (reported on Form 4 filed 2026-06-29); transaction code A = award/grant.
• Shares granted: 10,000 RSUs; reported acquisition price: $0.00 (award).
• Vesting: 10,000 shares vest on June 25, 2027 (Footnote F1; filing notes RSUs granted under the Issuer's 2015 Stock Plan).
• Footnotes: F1 describes the one-year vesting schedule for this grant; F2 notes the filing includes RSUs that vest over various periods.
• Shares owned after transaction: not specified in the filing.
• Timeliness: Form 4 was filed within the required reporting window (not flagged as late).

Context

• RSUs are compensation awards that convert to actual shares only upon vesting; they are not an immediate market purchase or sale and do not necessarily signal a near-term trading intent.
• Because this is an awarded grant (price $0), it reflects company compensation decisions rather than an insider buying or selling stock.